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The acetylation mechanisms of several selected typical substrates from experiments, including arylamines and arylhydrazines, are
investigated with the density functional theory in this paper. The results indicate that all the transition states are characterized by
a four-membered ring structure, and hydralazine (HDZ) is the most potent substrate. The bioactivity for all the compounds is
increased in a sequence of PABA ≈ 4-AS < 4-MA < 5-AS ≈ INH < HDZ. The conjunction eﬀect and the delocalization of the
lone pairs of N atom play a key role in the reaction. All the results are consistent with the experimental data.
Copyright © 2009 Qing-An Qiao et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The arylamine N-acetyltransferases (NATs, EC 2.3.1.5) are
phase II metabolism enzymes found in both prokaryotes
and eukaryotes [1]. The N-acetylation reaction leads to the
detoxiﬁcation of arylamine xenobiotics and ﬁnally directs
to electrophilic arylnitrenium ions, which are considered
to be responsible for DNA adduct formation [2, 3]. To
Humans, the two functional NAT isozymes, NAT1 and
NAT2, show great diﬀerences in substrate speciﬁcity and
tissue distribution in spite of 81% amino acid sequence
identity [4]. The latter, NAT2, is expressed predominantly
in liver and intestinal epithelium [5]. Previous studies [2,
6, 7] have supposed that NATs catalyze an acetyl transfer
by a classical ping-pong kinetic mechanism (Scheme 1).
Site-directed mutagenesis analysis of human NAT2 and
Salmonella typhimurium NAT (StNAT) [7, 8] suggested that
a cysteine residue in the active site was responsible for
mediating the acetylation process. A recent presteady-state
and steady-state kinetic studies on p-nitrophenyl acetate
(PNPA) and NAT2 [9, 10] revealed that the catalytic
mechanism of NAT2 might depend on the formation of
a thiolate-imidazolium pair. Though the enzyme is found
in both eukaryotes and prokaryotes, the endogenous roles
of NATs are still unclear [11]. The substrate determination
revealed that both arylamines and arylhydrazines could be
acetylated by NATs [11–15]. The required steps in the acetyl
transfer reaction are composed of the acetyl group transfer
from the active site cysteine residue to the substrate, and
the removal of one proton from the latter to the former.
In this paper, a detailed theoretical study on the behaviors
of arylamines and arylhydrazines substrates in acetylation
is available, including the properties of their structures, the
transition states, the proﬁles of energies.
2.Methodologies
All calculations were performed with the density functional
theory (DFT) B3LYP [16–18] method as implemented in
Gaussian03 program package [19], which has previously
been successfully employed on a number of enzymatic
systems [20]. When 6-31G∗ and 6-311+G (3df, 2p) basis
sets were used, the B3LYP hybrid functional was preferred
to Hartree-Fock (HF) and MP2 methods [21, 22]. Though it
sometimes fails in treatment of dispersion-rich interactions,2 Research Letters in Biochemistry
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Scheme 1: The NATs catalyzed acetyl transfer reaction.
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Figure 1: The concerted and stepwise pathways for arylamine N-acetyltransferases catalyzed reaction.
the B3LYP method has been successfully applied on many
biological systems [23–25].
The geometries of all the reactants, intermediates, and
products are optimized at the B3LYP/6-31G∗ level of
theory. The most stable conformations as well as their
energies at every equilibration and transition states have
been ﬁgured out. Frequency calculations are performed to
all the resulting stationary points and each transition states
has only one imaginary frequency. Furthermore, MP2/6-
311+G∗∗ method is employed on the optimized structures
of stationary points to get more accuracy energy proﬁles. If
not specially pointed out, all the following energy analyses
refer to the results from MP2/6-311+G∗∗//B3LYP/6-31G (d)
calculations.
3. Results andDiscussion
3.1. The Substrates’ Frontier Obitals. Six substrates, p-
aminobenzoic acid(PABA), 4-methoxylaniline(4-MA), 4-
aminosalicylate (4-AS), 5-aminosalicylate(5-AS), isoniaz-
id(INZ), hydralazine (HDZ), are selected according the
references [11–15], which can be divided into two distinct
families: arylamines and arylhydrazines. The energies for
frontier obitals (including HOMO-2, HOMO-1, HOMO,
LUMO, LUMO+1 and LUMO+2) of all six substrates are
listed in Table 1, which are considered playing important
roles in bioenzymatic systems [26]. For the arylamines, the
HOMO energies are reduced in a sequence of 4-MA >
5-AS > PABA > 4-AS, which indicates the increasing of
their nucleophilic reactivity. Among all the six substrates
(see Figure 1 in the supplementary materials available online
at doi: 10.1155/2009/783035), INZ has the largest energy gap
between HOMOand LUMO,whichsuggestsits stability. The
Natural Population Analysis (NPA) results showed that the
active amino N atoms for the arylamines family are more
electronegative than those of the hydrazines group, which is
mainly caused by the conjugation eﬀect.
Though PABA and 4-AS have diﬀerent substitutions on
thep-siteoftheaminogroupatthesix-memberedring,their
bioactivities are nearly the same. An intermolecular H-bond
will stabilize the substrate itself with the energy drop about
19–21kJ/mol.BoththeHOMOandLOMOenergiesfor5-AS
are higher than those of 4-AS s, suggesting that the former is
more reactive than the latter.
For the arylhydrazines substrates, the lone pair of the
N atoms at the backbone of the six-membered ring will be
delocalized at the whole system so as to enhance its stability.
The E(L-H) values of HDZ is 0.0318 a.u. higher than that of
INZ’s, indicating its higher reactivity than the latter.
3.2. The Diﬀerent Pathways and Transition States. In princi-
ple, all the substrates can react with the active site cysteine
residue via a concerted pathway or a stepwise one. To the
former, the transition states (see Figures 1 and 2, con-ts)
experience a concerted transfer of the hydrogen H5 to S1
atom of cysteine and a bond formation between N4 and
C2 atoms. The broken of old bonds (N4H5 and S1C2) and
the formation of new ones (C2N4 and S1H5) take placeResearch Letters in Biochemistry 3
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Figure 2: The structure of transition states for both concerted and stepwise pathway of PABA.
Table 1: The energies of the frontier orbitals.
Energy/a.u. HOMO-2 HOMO-1 HOMO LUMO LUMO+1 LUMO+2 E(L-H)
(a)
PABA −0.4469 −0.3636 −0.3183 0.0536 0.0660 0.0749 0.3791
4-MA −0.4366 −0.3398 −0.2890 0.0693 0.0815 0.0863 0.3583
4-AS −0.4597 −0.3443 −0.3244 0.0525 0.0627 0.0729 0.3769
5-AS −0.4419 −0.3641 −0.2924 0.0611 0.0619 0.0697 0.3535
INZ −0.4162 −0.3850 −0.3484 0.0599 0.0655 0.0787 0.4083
HDZ −0.3822 −0.3664 −0.3171 0.0590 0.0605 0.0656 0.3761
(a)E(L-H) refers to the energy diﬀerence between HOMO and LUMO.
con-ts
stw-ts1
stw-ts2
intmed
Reactants
Products Products
0
50
100
150
200
R
e
l
a
t
i
v
e
e
n
e
r
g
y
(
k
J
/
m
o
l
)
PABA
4-MA
4-AS
5-AS
IHZ
HDZ
Figure 3: The energy proﬁles for all substrates.
simultaneously. The reactants and the target products are
connectedbytheonlytransitionstateonthepotentialenergy
surface (PES). The main structure data of all transition states
are listed in Table 1 of the supplementary materials. For the
stepwise mechanism, H5 atom will be ﬁrstly transferred to
the O3 atom of the carbonyl group, tending to generate a
new bond between N4 and C2 atom via transition state stw-
ts1. Then, a thiolester intermediate (intmed) will be formed.
Consequently, the second migration of H5 will take place
fromthehydroxylgrouptoS1atomviastw-ts2togetherwith
the rupture of S1-C2 bond, which will ﬁnally direct to the
products.
The results indicate that all the transition states are
characterized by a four-membered ring structure which is
nearly planar. There are two small angles less than 80◦
in every transition state (C2S1H5 and S1C2N4 for con-ts,
C2O3H5 and C2N4H5 for stp-ts1, C2S1H5 and S1C2O3
for stp-ts2), which bring great strain to the whole system
and make it unstable. Among the six concerted transition
states(con-ts)ofallthesubstrates,thepropertiesofthebond
C2N4, N4H5 and S1H5 are roughly the same for all the
substrates, while the interaction between S1 and C2 is one
of the determining factors for the concerted step.
Things become diﬀerent for the stepwise pathways. The
hybridization changes of C2 atom follow a similar tendency
(sp3 → sp2 → sp3) for all the substrates during the stepwise
acetylating (Table 1 supplementary). The ﬁrst migration
of H5 will lead to transition state stp-ts1, and then an
intermediate named intmed is located on the potential
energy surface (PES), which is a local minimum. It is a
tetrahedral thiolester intermediate as proposed in previous
experimental studies [10]. It is short-lived and a consequent
H5 transfer will soon occur via transition state stp-ts2.F o r
the stepwise pathway, the structures of the traction states
for diﬀerent substrates diﬀer very little with others. The
3D structures of the transition states were listed for PABA
(Figure 2), the other ones were similar to those.
3.3. The Energies. T h er e l a t i v ee n e r g i e so fa l lp o s s i b l e
pathways for the six substrates are carried out based on the4 Research Letters in Biochemistry
energy sum of the reactants taken as zero (Figure 3). From
Figure 3, we ﬁnd that the concerted pathways are favored to
thestepwiseones.Theenergybarriersofconcertedtransition
states (con-ts) are lower than those of the stepwise ones
(stp-ts1) at a range of 83.5kJ/mol to 26.9kJ/mol (Table
2 supplementary). The arylhydrazines are better substrates
than the arylamines, and HDZ is the most reactive one with
the lowest activation energy, which meets the experimental
data with good agreement [12]. This conclusion could
be also drawn from the structure data analysis (Table 1
supplementary). The enhanced conjunction eﬀect and the
delocalization of the nitrogen lone pairs at the backbone
stabilized the transition state. The bioactivity for all the
substrates is increased in a sequence of PABA ≈ 4 − AS <
4 −MA < 5 −AS ≈ INH < HDZ.
4. Conclusions
The following conclusions can be drawn.
(i) All the substrate can be acetylated via two diﬀerent
pathways: the concerted and the stepwise, and the
former is much preferred owing to the lower activa-
tion energies.
(ii) From our calculation, arylhydrazines are better sub-
strates than the arylamines, and HDZ is the most
reactive one with the lowest activation energy. The
bioactivity for all the substrates is increased in a
sequence as PABA ≈ 4 − AS < 4 − MA < 5 −
AS ≈ INH < HDZ, which is consistent with the
experimental results very well [12].
(iii) The conjunction eﬀect and the delocalized lone
pairs play very important roles in acetylation. The
enhancedconjunctioneﬀectandtheincreasingnum-
bers of the lone pairs at the six-membered ring will
lead to the lower energy barrier.
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